Trial Profile
Clinical Trials Insight: 700039540
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2008
Price :
$35
*
At a glance
- Drugs Canakinumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Novartis
- 05 Dec 2008 New trial record.